Becton Dickinson Gross Profit 2010-2024 | BDX

Becton Dickinson annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Becton Dickinson gross profit for the quarter ending September 30, 2024 was $2.515B, a 47.77% increase year-over-year.
  • Becton Dickinson gross profit for the twelve months ending September 30, 2024 was $9.153B, a 12.03% increase year-over-year.
  • Becton Dickinson annual gross profit for 2024 was $9.153B, a 12.03% increase from 2023.
  • Becton Dickinson annual gross profit for 2023 was $8.17B, a 3.62% decline from 2022.
  • Becton Dickinson annual gross profit for 2022 was $8.477B, a 1.78% decline from 2021.
Becton Dickinson Annual Gross Profit
(Millions of US $)
2024 $9,153
2023 $8,170
2022 $8,477
2021 $8,631
2020 $6,798
2019 $8,288
2018 $7,269
2017 $5,965
2016 $5,991
2015 $4,695
2014 $4,301
2013 $4,171
2012 $3,953
2011 $3,959
2010 $3,696
2009 $3,675
Becton Dickinson Quarterly Gross Profit
(Millions of US $)
2024-09-30 $2,515
2024-06-30 $2,307
2024-03-31 $2,304
2023-12-31 $2,027
2023-09-30 $1,702
2023-06-30 $2,100
2023-03-31 $2,235
2022-12-31 $2,133
2022-09-30 $2,077
2022-06-30 $2,067
2022-03-31 $2,113
2021-12-31 $2,220
2021-09-30 $1,695
2021-06-30 $1,958
2021-03-31 $2,246
2020-12-31 $2,732
2020-09-30 $1,427
2020-06-30 $1,660
2020-03-31 $1,733
2019-12-31 $1,978
2019-09-30 $2,267
2019-06-30 $2,074
2019-03-31 $1,974
2018-12-31 $1,973
2018-09-30 $2,094
2018-06-30 $2,016
2018-03-31 $1,606
2017-12-31 $1,553
2017-09-30 $1,578
2017-06-30 $1,503
2017-03-31 $1,432
2016-12-31 $1,452
2016-09-30 $1,553
2016-06-30 $1,547
2016-03-31 $1,483
2015-12-31 $1,408
2015-09-30 $1,430
2015-06-30 $1,174
2015-03-31 $1,046
2014-12-31 $1,045
2014-09-30 $1,102
2014-06-30 $1,111
2014-03-31 $1,053
2013-12-31 $1,035
2013-09-30 $1,087
2013-06-30 $1,060
2013-03-31 $1,018
2012-12-31 $1,006
2012-09-30 $1,001
2012-06-30 $1,033
2012-03-31 $988
2011-12-31 $931
2011-09-30 $952
2011-06-30 $1,029
2011-03-31 $1,001
2010-12-31 $977
2010-09-30 $839
2010-06-30 $947
2010-03-31 $935
2009-12-31 $974
2009-09-30 $898
2009-06-30 $960
2009-03-31 $896
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $64.746B $20.178B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.108B 21.59
Cardinal Health (CAH) United States $29.487B 15.99
West Pharmaceutical Services (WST) United States $22.928B 46.83
Cooper (COO) United States $20.075B 28.58
Labcorp (LH) United States $20.046B 16.62
Align Technology (ALGN) United States $16.863B 32.27
Henry Schein (HSIC) United States $9.361B 17.83
Merit Medical Systems (MMSI) United States $6.139B 31.35
DENTSPLY SIRONA (XRAY) United States $3.731B 10.15
CONMED (CNMD) United States $2.314B 19.31
Patterson (PDCO) United States $1.803B 9.52
STAAR Surgical (STAA) United States $1.315B 48.51
Lifevantage (LFVN) United States $0.178B 23.67
Pro-Dex (PDEX) United States $0.152B 30.36